DCAT Announces New Board of Directors

Paolo Magri, senior vice president, business development at Advitech, has been...
Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT).

Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to serve as officers of DCAT are: Stephan Kutzer, president and CEO of Alcami, as first vice president; Sean Diver, director, business development, early intermediates at Lonza, as second vice president; and Kerri McCullough Wood, senior vice president and head of commercial, TAPI, Teva. All will serve one-year terms, effective Nov. 1, 2018.

In addition, the following individuals have been newly elected or will continue to serve one-year terms on the board.

Directors:

Elodie Cramer, associate director, Global Procurement, Biogen

Charles Davies, associate vice president, Global Sourcing & Procurement, Merck & Co.

Sally Macaluso, Vice president, Johnson & Johnson Marketing and Business Services Procurement, Johnson & Johnson

Steve Poland, global director, 3rd Party FDF Technical Support, Mylan

Sami Yusuf, vice president, Corporate Development, Upsher-Smith

Past Presidents:

Immediate Past President: Joe Sutton, Global Director, Sourcing, Eli Lilly

2nd Immediate Past President: Milton Boyer, CEO, SCA Pharmaceuticals

Company

Logo:

DCAT - Drug, Chemical & Associated Technologies Association

One Union St., Suite 208
Robbinsville
US

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.